WAT Net Income Growth
-74.88%TTM
Period ending:
WAT TTM Net Income YoY %%
4524.00%-1924.00%
1996-12-312026-07-04
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
WAT net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 119 observations from Dec 31, 1996 to Jul 4, 2026.
| Period ending | Net Income Growth |
|---|---|
| -74.8807% | |
| -31.6233% | |
| 0.7518% | |
| 4.2034% | |
| 11.0297% | |
| 8.8668% | |
| -0.6851% | |
| -4.6624% | |
| -11.6891% | |
| -12.3888% | |
| -9.2576% | |
| -6.2906% | |
| -3.9284% | |
| -2.2284% | |
| 2.1523% | |
| 0.2903% | |
| 6.3013% | |
| 14.3493% | |
| 32.8377% | |
| 37.8994% | |
| 28.1793% | |
| 14.785% | |
| -11.9262% | |
| -12.6156% | |
| -11.0892% | |
| -9.149% | |
| -0.2688% | |
| 939.6268% | |
| 1,046.2856% | |
| 2,112.4284% | |
| 2,823.5094% | |
| -89.8752% | |
| -90.5779% | |
| -94.9898% | |
| -96.1053% | |
| 9.9727% | |
| 9.6014% | |
| 14.1237% | |
| 11.1821% | |
| 6.1557% | |
| 4.9511% | |
| 2.1131% | |
| 8.6727% | |
| 11.2301% | |
| 14.7729% | |
| 14.5607% | |
| -4.0851% | |
| -12.8942% | |
| -16.2672% | |
| -19.1541% | |
| -2.4792% | |
| 14.603% | |
| 14.2733% | |
| 15.6132% | |
| 6.5767% | |
| 0.0523% | |
| 2.1417% | |
| 6.5907% | |
| 13.4128% | |
| 17.5748% | |
| 22.1404% | |
| 23.1194% | |
| 18.0785% | |
| 12.7892% | |
| 8.4012% | |
| -0.5703% | |
| 0.2586% | |
| -1.0948% | |
| 3.377% | |
| 16.6569% | |
| 20.2957% | |
| 29.3356% | |
| 23.4601% | |
| 19.928% | |
| 20.6445% | |
| 14.2761% | |
| 27.3537% | |
| 17.2636% | |
| 10.0136% | |
| 10.114% | |
| -13.7727% | |
| -13.1713% | |
| -9.8539% | |
| -6.1838% | |
| 14.6895% | |
| 29.2778% | |
| 31.1087% | |
| 38.109% | |
| 25.7947% | |
| 17.6083% | |
| 15.692% | |
| 44.0171% | |
| 47.5583% | |
| 41.6714% | |
| 28.9577% | |
| -31.7928% | |
| -31.7858% | |
| -30.4617% | |
| -21.1902% | |
| 5.6176% |
Compare net income growth
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) net income growth
- Johnson & Johnson (JNJ) net income growth
- AbbVie (ABBV) net income growth
- UnitedHealth Group (UNH) net income growth
- Merck & Co. (MRK) net income growth
- Thermo Fisher Scientific (TMO) net income growth
- Amgen (AMGN) net income growth
- Gilead Sciences (GILD) net income growth
Compare all covered stocks by net income growth →
All WAT financial metrics · WAT stock overview · How to interpret financial metrics
